Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands. Issue 5 (5th February 2021)
- Record Type:
- Journal Article
- Title:
- Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands. Issue 5 (5th February 2021)
- Main Title:
- Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands
- Authors:
- Magli, Elisa
Kędzierska, Ewa
Kaczor, Agnieszka A.
Bielenica, Anna
Severino, Beatrice
Gibuła‐Tarłowska, Ewa
Kotlińska, Jolanta H.
Corvino, Angela
Sparaco, Rosa
Esposito, Giovanna
Albrizio, Stefania
Perissutti, Elisa
Frecentese, Francesco
Leśniak, Anna
Bujalska‐Zadrożny, Magdalena
Struga, Marta
Capasso, Raffaele
Santagada, Vincenzo
Caliendo, Giuseppe
Fiorino, Ferdinando - Abstract:
- Abstract: A new series of norbornene and exo ‐ N ‐hydroxy‐7‐oxabicyclo[2.2.1]hept‐5‐ene‐2, 3‐dicarboximide derivatives was prepared, and their affinities to the 5‐HT1A, 5‐HT2A, and 5‐HT2C receptors were evaluated and compared with a previously synthesized series of derivatives characterized by the same nuclei, to identify selective ligands for the subtype receptors. Arylpiperazines represent one of the most important classes of 5‐HT1A R ligands, and the research of new derivatives has been focused on the modification of one or more portions of this pharmacophore. The combination of structural elements (heterocyclic nucleus, hydroxyalkyl chain, and 4‐substituted piperazine), known to be critical for the affinity to 5‐HT1A receptors, and the proper selection of substituents resulted in compounds with high specificity and affinity toward serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that 3e, 4j, and 4n were the most active and promising derivatives for the serotonin receptor considered in this study. Abstract : Several norbornene and exo ‐ N ‐hydroxy‐7‐oxabicyclo[2.2.1]hept‐5‐ene‐2, 3‐dicarboximide derivatives with affinity toward 5‐HT1A, 5‐HT2A, and 5‐HT2C receptors are described in this study. Among these, the compound containing a naphthylpiperazineAbstract: A new series of norbornene and exo ‐ N ‐hydroxy‐7‐oxabicyclo[2.2.1]hept‐5‐ene‐2, 3‐dicarboximide derivatives was prepared, and their affinities to the 5‐HT1A, 5‐HT2A, and 5‐HT2C receptors were evaluated and compared with a previously synthesized series of derivatives characterized by the same nuclei, to identify selective ligands for the subtype receptors. Arylpiperazines represent one of the most important classes of 5‐HT1A R ligands, and the research of new derivatives has been focused on the modification of one or more portions of this pharmacophore. The combination of structural elements (heterocyclic nucleus, hydroxyalkyl chain, and 4‐substituted piperazine), known to be critical for the affinity to 5‐HT1A receptors, and the proper selection of substituents resulted in compounds with high specificity and affinity toward serotoninergic receptors. The most active compounds were selected for further in vivo assays to determine their functional activity. Finally, to rationalize the obtained results, molecular docking studies were performed. The results of the pharmacological studies showed that 3e, 4j, and 4n were the most active and promising derivatives for the serotonin receptor considered in this study. Abstract : Several norbornene and exo ‐ N ‐hydroxy‐7‐oxabicyclo[2.2.1]hept‐5‐ene‐2, 3‐dicarboximide derivatives with affinity toward 5‐HT1A, 5‐HT2A, and 5‐HT2C receptors are described in this study. Among these, the compound containing a naphthylpiperazine moiety (4n ) showed an interesting antagonist profile at the 5‐HT1A receptor. … (more)
- Is Part Of:
- Archiv der Pharmazie. Volume 354:Issue 5(2021)
- Journal:
- Archiv der Pharmazie
- Issue:
- Volume 354:Issue 5(2021)
- Issue Display:
- Volume 354, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 354
- Issue:
- 5
- Issue Sort Value:
- 2021-0354-0005-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-02-05
- Subjects:
- 5‐HT1A receptor ligands -- arylpiperazine derivatives -- exo‐N‐hydroxy‐7‐oxabicyclo[2.2.1]hept‐5‐ene‐2, 3‐dicarboximide -- norbornene nucleus -- serotonin
Pharmaceutical chemistry -- Periodicals
Pharmacology -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4184 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ardp.202000414 ↗
- Languages:
- English
- ISSNs:
- 0365-6233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1622.800000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16757.xml